These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38010652)

  • 21. Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
    Fleet JL; Weir MA; McArthur E; Ozair S; Devereaux PJ; Roberts MA; Jain AK; Garg AX
    Am J Kidney Dis; 2014 Dec; 64(6):883-91. PubMed ID: 25037562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Albuminuria and Regression of Chronic Kidney Disease in Adults With Newly Diagnosed Moderate to Severe Chronic Kidney Disease.
    Pasternak M; Liu P; Quinn R; Elliott M; Harrison TG; Hemmelgarn B; Lam N; Ronksley P; Tonelli M; Ravani P
    JAMA Netw Open; 2022 Aug; 5(8):e2225821. PubMed ID: 35943741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis.
    Wu CL; Chang CC; Kor CT; Yang TH; Chiu PF; Tarng DC; Hsu CC
    Clin J Am Soc Nephrol; 2018 May; 13(5):702-709. PubMed ID: 29661770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate for psoriatic arthritis.
    Wilsdon TD; Whittle SL; Thynne TR; Mangoni AA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012722. PubMed ID: 30656673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
    D'Andrea E; Desai RJ; He M; Glynn RJ; Lee H; Weinblatt ME; Kim SC
    J Am Coll Cardiol; 2022 Jul; 80(1):36-46. PubMed ID: 35772915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury.
    Omotoso BA; Turgut F; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
    Nephron; 2017; 136(2):95-102. PubMed ID: 28249270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion.
    Schneeweiss MC; Savage TJ; Wyss R; Jin Y; Schoder K; Merola JF; Sidbury R; Oduol T; Schneeweiss S; Glynn RJ
    JAMA Dermatol; 2023 Mar; 159(3):289-298. PubMed ID: 36753234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
    Fu X; Ren H; Xie J; Wang W; Li Y; Gao P; Chen N
    JAMA Netw Open; 2022 May; 5(5):e2214460. PubMed ID: 35616936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
    Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
    JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
    Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
    JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD.
    Bourrier M; Ferguson TW; Embil JM; Rigatto C; Komenda P; Tangri N
    Am J Kidney Dis; 2020 May; 75(5):705-712. PubMed ID: 31879218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
    Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
    Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial.
    Sparks JA; Vanni KMM; Sparks MA; Xu C; Santacroce LM; Glynn RJ; Ridker PM; Solomon DH
    J Am Soc Nephrol; 2021 Dec; 32(12):3197-3207. PubMed ID: 34551998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
    Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
    Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease.
    Cowan A; Jeyakumar N; Kang Y; Dixon SN; Garg AX; Naylor K; Weir MA; Clemens KK
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):835-842. PubMed ID: 35618342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.